Olanzapine For Alzheimer's Disease
   Olanzapine is a drug normally used to treat psychosis,in particular,schizophrenia. It was approved by
the FDA in 1996 and is marketed under the trade name Zyprexa,manufactured by Eli
Lilly. The drug is now being used to treat alzheimer patients. The normal dose
is 5 milligrams daily when used to control psychotic symptoms in alzheimer
patients [139]. One recent study reports that 5 to 10 milligrams olanzapine
daily effectively reduces aggression, hallucinations, and delusions in alzheimer
patients. The most common side effects are a tendency to sleep more and a
disturbed gait. Olanzapine does not alter cognition or produce extrapyramidal
effects [140].